结直肠癌诊断后咖啡摄入与死亡率降低之间的关联
基于护士健康研究(1984-2012)和卫生专业人员随访研究(1986-2012)的前瞻性数据,纳入1599例1-3期结直肠癌患者,分析诊断后咖啡摄入与死亡率的关联。中位随访7.8年期间记录803例死亡(其中188例为结直肠癌特异性死亡)。多变量调整后,与不饮用者相比,每日至少4杯咖啡者结直肠癌特异性死亡风险降低52%(HR 0.48;95%CI 0.28-0.83;趋势P=.003),全因死亡风险降低30%(HR 0.70;95%CI 0.54-0.91;趋势P<.001)。
要点
- 诊断后每日至少4杯咖啡与结直肠癌特异性死亡风险降低52%相关(HR 0.48;95%CI 0.28-0.83)。
- 诊断后每日至少4杯咖啡与全因死亡风险降低30%相关(HR 0.70;95%CI 0.54-0.91)。
- 含咖啡因和脱咖啡因咖啡(每日2杯或以上)均与结直肠癌特异性死亡和全因死亡风险降低相关。
核心结论
- 在护士健康研究和卫生专业人员随访研究的数据分析中,结直肠癌诊断后摄入含咖啡因和脱咖啡因咖啡与结直肠癌特异性死亡和全因死亡风险降低相关。
- 需要研究来确定咖啡可能减少结直肠癌进展的机制。
研究设计与样本
- 前瞻性研究,数据来自护士健康研究(1984-2012)和卫生专业人员随访研究(1986-2012),随访1599例诊断为1、2或3期结直肠癌的患者。
- 结直肠癌通过问卷报告并经医疗记录和病理报告审核确认;食物和饮料摄入通过半定量食物频率问卷确定。
- 诊断后摄入评估使用诊断后至少6个月但不超过4年的第一份问卷回复(从诊断到饮食评估的中位时间2.2年);诊断前饮食摄入使用诊断前最后一份半定量食物频率问卷。
主要发现
- 中位随访7.8年期间记录803例死亡,其中188例为结直肠癌特异性死亡。
- 多变量调整模型中,与不饮用者相比,每日至少4杯咖啡者结直肠癌特异性死亡风险降低52%(HR 0.48;95%CI 0.28-0.83;趋势P=.003),全因死亡风险降低30%(HR 0.70;95%CI 0.54-0.91;趋势P<.001)。
- 高摄入含咖啡因和脱咖啡因咖啡(每日2杯或以上)与结直肠癌特异性死亡和全因死亡风险降低相关。
- 与持续低摄入(每日少于2杯)者相比,维持高摄入(每日2杯或以上)者结直肠癌特异性死亡风险显著降低(多变量HR 0.63;95%CI 0.44-0.89),全因死亡风险显著降低(多变量HR 0.71;95%CI 0.60-0.85)。
局限性
- 需要研究来确定咖啡可能减少结直肠癌进展的机制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Few studies have examined the association between coffee intake and survival after diagnosis of colorectal cancer (CRC). We performed a prospective study to investigate the association between coffee intake after a diagnosis of CRC and mortality. METHODS: We collected data from the Nurses' Health Study (1984-2012) and Health Professionals Follow-up Study (1986-2012), following 1599 patients diagnosed with stage 1, 2, or 3 CRC. CRC was reported on questionnaires and ascertained by review of medical records and pathology reports; intake of food and beverages was determined from responses to semi-quantitative food frequency questionnaires. Participants were asked how often during the previous year that they consumed coffee, with 1 cup as the standard portion size. The first questionnaire response collected at least 6 months but not more than 4 years after diagnosis was used for assessment of post-diagnostic intake (median time from diagnosis to the dietary assessment, 2.2 years). The last semi-quantitative food frequency questionnaire prior to diagnosis was used to assess pre-diagnostic dietary intake. RESULTS: During a median of 7.8 years of follow-up, we documented 803 deaths, of which 188 were because of CRC. In the multivariable adjusted models, compared with nondrinkers, patients who consumed at least 4 cups of coffee per day had a 52% lower risk of CRC-specific death (hazard ratio [HR] 0.48; 95% CI, 0.28-0.83; P for trend=.003) and 30% reduced risk of all-cause death (HR, 0.70; 95% CI, 0.54-0.91; P for trend <.001). High intake of caffeinated and decaffeinated coffee (2 or more cups/day) was associated with lower risk of CRC-specific mortality and all-cause mortality. When coffee intake before vs after CRC diagnosis were examined, compared with patients consistently consuming low amounts (less than 2 cups/day), those who maintained a high intake (2 or more cups/day) had a significantly lower risk of CRC-specific death (multivariable HR, 0.63; 95% CI, 0.44-0.89) and death from any cause (multivariable HR, 0.71; 95% CI, 0.60-0.85). CONCLUSIONS: In an analysis data from the Nurses' Health Study and Health Professionals Follow-up Study, we associated intake of caffeinated and decaffeinated coffee after diagnosis of CRC with lower risk of CRC-specific death and overall death. Studies are needed to determine the mechanisms by which coffee might reduce CRC progression.
引用
- Hu Y, Ding M, Yuan C, et al. Association Between Coffee Intake After Diagnosis of Colorectal Cancer and Reduced Mortality. Gastroenterology. 2017. PMID: 29158191. doi:10.1053/j.gastro.2017.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。